BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 31590941)

  • 1. ABO Blood Group and Transfusions In the Intraoperative and Postoperative Period After LVAD Implantation.
    Sun GH; Bruguera C; Saadat S; Moss D; Schumann R; Welsby IJ; Brovman EY; Cobey FC
    J Cardiothorac Vasc Anesth; 2020 Apr; 34(4):906-911. PubMed ID: 31590941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraoperative prothrombin complex concentrate administration and outcomes in patients undergoing left ventricular assist device implantation.
    Boswell MR; Stulak JM; Tchantchaleishvili V; Weber MP; Warner MA; Smith BB; Smith MM
    Artif Organs; 2021 Aug; 45(8):E223-E303. PubMed ID: 33469913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of early massive transfusion and blood component ratios in patients undergoing left ventricular assist device implantation.
    Hong Y; Dufendach K; Wang Y; Thoma F; Kilic A
    J Card Surg; 2021 Dec; 36(12):4519-4526. PubMed ID: 34558110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting Transfusions During Left Ventricular Assist Device Implant.
    Miller RJH; Gregory AJ; Kent W; Banerjee D; Hiesinger W; Clarke B
    Semin Thorac Cardiovasc Surg; 2020 Winter; 32(4):747-755. PubMed ID: 31128255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive value of the model for end-stage liver disease score in patients undergoing left ventricular assist device implantation.
    Deo SV; Daly RC; Altarabsheh SE; Hasin T; Zhao Y; Shah IK; Stulak JM; Boilson BA; Schirger JA; Joyce LD; Park SJ
    ASAIO J; 2013; 59(1):57-62. PubMed ID: 23263341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Postoperative Liver Dysfunction on Survival After Left Ventricular Assist Device Implantation.
    Majumder K; Spratt JR; Holley CT; Roy SS; Cogswell RJ; Liao K; John R
    Ann Thorac Surg; 2017 Nov; 104(5):1556-1562. PubMed ID: 28760474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perioperative blood product use: a comparison between HeartWare and HeartMate II devices.
    Haglund NA; Davis ME; Tricarico NM; Ahmad RM; DiSalvo TG; Keebler ME; Schlendorf KH; Wigger MA; Stulak JM; Maltais S
    Ann Thorac Surg; 2014 Sep; 98(3):842-9. PubMed ID: 25085559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does postoperative blood pressure influence development of aortic regurgitation following continuous-flow left ventricular assist device implantation?†.
    Patil NP; Mohite PN; Sabashnikov A; Dhar D; Weymann A; Zeriouh M; Koch A; Garcia-Saez D; Zych B; Hards R; Hedger M; De Robertis F; Moza A; Bahrami T; Amrani M; Rahman-Haley S; Popov AF; Banner N; Simon AR
    Eur J Cardiothorac Surg; 2016 Mar; 49(3):788-94. PubMed ID: 26108216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low incidence of bleeding-related morbidity with left ventricular assist device implantation in the current era.
    Krishan K; Nair A; Pinney S; Adams D; Anyanwu AC
    Artif Organs; 2012 Aug; 36(8):746-51. PubMed ID: 22607225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of adenosine diphosphate receptor inhibitor prior to left ventricular assist device implantation is not associated with increased bleeding.
    Tibrewala A; Nassif ME; Andruska A; Shuster JE; Novak E; Vader JM; Ewald GA; LaRue SJ; Silvestry S; Itoh A
    J Artif Organs; 2017 Mar; 20(1):42-49. PubMed ID: 27830349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary Bleeding During Right Ventricular Support After Left Ventricular Assist Device Implantation.
    Welp H; Sindermann JR; Deschka H; Martens S; Scherer M
    J Cardiothorac Vasc Anesth; 2016 Jun; 30(3):627-31. PubMed ID: 26460277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Avoidance of cellular blood product transfusions in LVAD recipients does not prevent HLA allosensitization.
    Stringham JC; Bull DA; Fuller TC; Kfoury AG; Taylor DO; Renlund DG; Karwande SV
    J Heart Lung Transplant; 1999 Feb; 18(2):160-5. PubMed ID: 10194040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can Intraoperative Transesophageal Echocardiography Predict Postoperative Aortic Insufficiency in Patients Receiving Implantable Left Ventricular Assist Devices?
    Kellman SE; Feider AJ; Jeevanandam V; Chaney MA
    J Cardiothorac Vasc Anesth; 2015 Aug; 29(4):901-5. PubMed ID: 25939966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prior Sternotomy and Ventricular Assist Device Implantation Do Not Adversely Impact Survival or Allograft Function After Heart Transplantation.
    Gaffey AC; Phillips EC; Howard J; Hung G; Han J; Emery R; Goldberg L; Acker MA; Woo YJ; Atluri P
    Ann Thorac Surg; 2015 Aug; 100(2):542-9. PubMed ID: 26070597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood Product Utilization with Left Ventricular Assist Device Implantation: A Decade of Statewide Data.
    Quader M; LaPar DJ; Wolfe L; Ailawadi G; Rich J; Speir A; Fonner C; Kasirajan V;
    ASAIO J; 2016; 62(3):268-73. PubMed ID: 26809087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of early inhaled epoprostenol therapy on pulmonary artery pressure and blood loss during LVAD placement.
    Groves DS; Blum FE; Huffmyer JL; Kennedy JL; Ahmad HB; Durieux ME; Kern JA
    J Cardiothorac Vasc Anesth; 2014 Jun; 28(3):652-60. PubMed ID: 24103713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postoperative right ventricular failure after left ventricular assist device placement is predicted by preoperative echocardiographic structural, hemodynamic, and functional parameters.
    Raina A; Seetha Rammohan HR; Gertz ZM; Rame JE; Woo YJ; Kirkpatrick JN
    J Card Fail; 2013 Jan; 19(1):16-24. PubMed ID: 23273590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence, predictors and clinical outcome of early bleeding events in patients undergoing a left ventricular assist device implant.
    Muslem R; Caliskan K; van Thiel R; Kashif U; Akin S; Birim O; Constantinescu AA; Brugts JJ; Bunge JJH; Bekkers JA; Leebeek FWG; Bogers AJJC
    Eur J Cardiothorac Surg; 2018 Jul; 54(1):176-182. PubMed ID: 29481654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-operative heparin may not be required for transitioning patients with a HeartMate II left ventricular assist system to long-term warfarin therapy.
    Slaughter MS; Naka Y; John R; Boyle A; Conte JV; Russell SD; Aaronson KD; Sundareswaran KS; Farrar DJ; Pagani FD
    J Heart Lung Transplant; 2010 Jun; 29(6):616-24. PubMed ID: 20400335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Independent risk factors for ICU mortality after left ventricular assist device implantation.
    Piffard M; Nubret-Le Coniat K; Simon O; Leuillet S; Rémy A; Barandon L; Ouattara A
    Artif Organs; 2020 Feb; 44(2):153-161. PubMed ID: 31318978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.